Background. Nebulisers are devices delivering aerosol therapy in asthmatic and COPD patients. Materials and methods. Comparison of two multicentre, observational surveys performed on 1999 and 2008. Both studies included a large population of Italian patients suffering from asthma or COPD and regularly using home nebuliser therapy. All enrolled subjects were assessed during a scheduled outpatient pulmonary visit. They gave information about their nebuliser treatment by a standardised self-compiled questionnaire. Results. The 1 st study included 816 subjects (40% had over 70 years of age; males 75%, females 25%; asthmatics 40%, COPD 60%). The 2nd study enrolled 151 subjects (48% over 70 years of age; males 82%, females 18%; asthmatics 47%, COPD 53%). The populations did not differ for gender, age, and primary respiratory diagnosis. The most commonly used medications were beta2-agonists, anticholinergics, and corticosteroids; nebulised drugs and their dosage did not differ between the studies. Coadmixture of more drugs was ubiquitous and performed by more than 90% of patients. Almost 80% of enrolled subjects for both studies selected their nebuliser themselves without any medical advice. The equipment was heterogeneous, but jet nebulisers accounted for more than 90% of the total. In the 1st investigation half of subjects had a glass reservoir vs. 15% in the 2nd study. Conclusions. We conclude that home nebuliser therapy remains common in Italy. Mixing of more drugs and the widespread use of corticosteroids were and remain peculiarities in our country. Health care givers can improve nebulizer practice by giving more education to their patients.

Romano, F., Scarlato, M.I., Canessa, P.A., Scichilone, N., Sestini, P., Neri, M., et al. (2013). Home nebuliser therapy in asthmatic and COPD patients: Is this practice changing in Italy? [Aerosolterapia domiciliare con nebulizzatori in asma e BPCO: Cosa sta cambiando in Italia?]. RASSEGNA DI PATOLOGIA DELL’APPARATO RESPIRATORIO, 28(1), 36-41.

Home nebuliser therapy in asthmatic and COPD patients: Is this practice changing in Italy? [Aerosolterapia domiciliare con nebulizzatori in asma e BPCO: Cosa sta cambiando in Italia?]

SESTINI, PIERSANTE;
2013-01-01

Abstract

Background. Nebulisers are devices delivering aerosol therapy in asthmatic and COPD patients. Materials and methods. Comparison of two multicentre, observational surveys performed on 1999 and 2008. Both studies included a large population of Italian patients suffering from asthma or COPD and regularly using home nebuliser therapy. All enrolled subjects were assessed during a scheduled outpatient pulmonary visit. They gave information about their nebuliser treatment by a standardised self-compiled questionnaire. Results. The 1 st study included 816 subjects (40% had over 70 years of age; males 75%, females 25%; asthmatics 40%, COPD 60%). The 2nd study enrolled 151 subjects (48% over 70 years of age; males 82%, females 18%; asthmatics 47%, COPD 53%). The populations did not differ for gender, age, and primary respiratory diagnosis. The most commonly used medications were beta2-agonists, anticholinergics, and corticosteroids; nebulised drugs and their dosage did not differ between the studies. Coadmixture of more drugs was ubiquitous and performed by more than 90% of patients. Almost 80% of enrolled subjects for both studies selected their nebuliser themselves without any medical advice. The equipment was heterogeneous, but jet nebulisers accounted for more than 90% of the total. In the 1st investigation half of subjects had a glass reservoir vs. 15% in the 2nd study. Conclusions. We conclude that home nebuliser therapy remains common in Italy. Mixing of more drugs and the widespread use of corticosteroids were and remain peculiarities in our country. Health care givers can improve nebulizer practice by giving more education to their patients.
2013
Romano, F., Scarlato, M.I., Canessa, P.A., Scichilone, N., Sestini, P., Neri, M., et al. (2013). Home nebuliser therapy in asthmatic and COPD patients: Is this practice changing in Italy? [Aerosolterapia domiciliare con nebulizzatori in asma e BPCO: Cosa sta cambiando in Italia?]. RASSEGNA DI PATOLOGIA DELL’APPARATO RESPIRATORIO, 28(1), 36-41.
File in questo prodotto:
File Dimensione Formato  
aerosol_aipo.pdf

non disponibili

Descrizione: articolo
Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 127.83 kB
Formato Adobe PDF
127.83 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1001846
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo